News and Media

2012

December 13, 2012
ABC Action News HealthCheck
Clinical trial could help patients with sepsis


November 1, 2012
Spectral Diagnostics Investor Presentation, Fall 2012


June 25, 2012
Spectral Diagnostics Annual General Meeting of Shareholders Presentation


May 17, 2012
MedGadget:
Five Questions for Dr. Paul Walker of Spectral Diagnostics


April 16, 2012
Medical News Today:
Sepsis Common In USA Hospitals, Unawareness High


April 16, 2012
Gloucester County Times, Carly Q. Romalino:
Cooper Hospital's Dr. Dellinger at the forefront of research on septic shock


April 11, 2012
Investor's Business Daily:
Tend Customers One At A Time To Uncover New Business


April 5, 2012
WHYY Newsworks:
Cooper Hospital leading FDA trial for sepsis treatment


March 26, 2012
Medical Device Daily:
Firm develops personalized approach for treating Sepsis


2011

December 5, 2011
Op-Ed by Spectral Diagnostics CEO in The Globe and Mail


August 2, 2011
Video: Spectral Diagnostics CEO Paul Walker talks about the market opportunity for the Company’s theranostics product for the treatment for severe sepsis


2010

September 13, 2010
Spectral to Present at Rodman & Renshaw Annual Global Investment Conference on September 13

Spectral's Rodman & Renshaw Presentation 


2009

Spectral & BioMS Audiocast View a slide presentation and audio recording by Dr. Paul Walker, President and CEO of Spectral and Mr. Kevin Giese, President and CEO of BioMS Medical where they discuss this collaboration and the opportunity for Toraymyxin™ in the treatment of severe sepsis.


© 2011 Spectral Diagnostics Inc.